Page last updated: 2024-11-05

ici 204,219 and Cardiomyopathies, Primary

ici 204,219 has been researched along with Cardiomyopathies, Primary in 2 studies

zafirlukast: a leukotriene D4 receptor antagonist

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kezeli, T1
Antelava, N1
Gongadze, N1
Pachkoria, K1
Bakuridze, K1
Wechsler, ME1
Garpestad, E1
Flier, SR1
Kocher, O1
Weiland, DA1
Polito, AJ1
Klinek, MM1
Bigby, TD1
Wong, GA1
Helmers, RA1
Drazen, JM1

Other Studies

2 other studies available for ici 204,219 and Cardiomyopathies, Primary

ArticleYear
[Influence of zafirlucast on the content of leukotrienes, biogenic amines and prostaglandins in blood and myocardium in epinephrine-induced heart injury].
    Georgian medical news, 2007, Issue:151

    Topics: Animals; Cardiomyopathies; Chinchilla; Epinephrine; Indoles; Leukotriene Antagonists; Phenylcarbamat

2007
Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast.
    JAMA, 1998, Feb-11, Volume: 279, Issue:6

    Topics: Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cardiomyopathies; Churg-Strauss Synd

1998